Some literatures reveal that IGF2BP3 (Insulin-like growth factor 2 mRNA-binding protein 3) is considered an oncogene in multiple tumors, including leukemia 5, glioma 6, oral cancer 7, among others 8. This evidence concerns the gene IGF2BP3 and leukemia.